Longevity Health Holdings, Inc. (NASDAQ:XAGE – Get Free Report)’s share price rose 3.4% during trading on Thursday . The stock traded as high as $0.3379 and last traded at $0.3156. 1,319 shares were traded during trading, a decline of 53% from the average session volume of 2,806 shares. The stock had previously closed at $0.3051.
Longevity Health Price Performance
The company has a market cap of $463,320.00, a price-to-earnings ratio of -0.06 and a beta of 0.38. The company’s 50-day simple moving average is $0.32 and its 200-day simple moving average is $0.33.
About Longevity Health
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
Featured Stories
- Five stocks we like better than Longevity Health
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Receive News & Ratings for Longevity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Longevity Health and related companies with MarketBeat.com's FREE daily email newsletter.
